AstraZeneca Plc and the University of Oxford are preparing to file for emergency use authorization (EUA) for their COVID-19 vaccine later this month or in early April. AstraZeneca and the University of Oxford will file for emergency use of their COVID-19 vaccine with the FDA this month or early next month. Pictured: A vial of the AstraZeneca COVID-19 vaccine, March 2021Researchers now have data on at least 150 cases of COVID-19 that they believe will show their immunization is safe and effective. Phase III trial to be available soon, in the coming weeks, and we plan to file for emergency use authorization shortly thereafter.' The data could also help determine what becomes of millions of coronavirus vaccine doses sitting in cold storage in warehouses across the U.S.

Source: Daily Mail March 12, 2021 19:19 UTC